Jennifer Stroka Cobb

This inventor holds 7 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2016-2025.

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 8(Granted Patents)

Location History:

Cambridge, MA (US) (2016)
Stow, MA (US) (2021 - 2023)

Company Filing History:

7 out of 3,975

Novartis Ag

patents

Years Active: 2016-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252482 - Pyrazolopyridine derivatives and uses thereof (2025-03-18),

2. 12172984 - Pyrazolopyridine derivatives and uses thereof (2024-12-24),

3. 12103919 - 3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2024-10-01),

4. 11787785 - Pyrazolopyridine derivatives and uses thereof (2023-10-17),

5. 11566022 - 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2023-01-31),

6. 10975120 - Site-specific chemoenzymatic protein modifications (2021-04-13),

7. 9359400 - Site-specific chemoenzymatic protein modifications (2016-06-07),

Title: Jennifer Stroka Cobb: Pioneering Innovations in Medical Treatments

Introduction: Jennifer Stroka Cobb, a remarkable inventor based in Stow, MA (US), has made significant contributions to the field of medical innovation. Her inventive spirit and dedication to excellence have set her apart as a leading figure in the world of patents and inventions.

Latest Patents: Jennifer Stroka Cobb holds four patents, with her latest inventions focusing on novel compounds and pharmaceutical compositions for treating inherited blood disorders like sickle cell disease and beta-thalassemia. One of her recent patents includes Pyrazolopyridine derivatives and uses thereof, which demonstrate potential in reducing Widely Interspaced Zinc Finger Motifs (WIZ) expression levels and inducing fetal hemoglobin (HbF) expression.

Career Highlights: Jennifer Stroka Cobb is currently associated with Novartis AG, a pharmaceutical company renowned for its innovative research and development initiatives. Her role at Novartis AG showcases her commitment to pioneering advancements in medical treatments and drug development.

Collaborations: Throughout her career, Jennifer Stroka Cobb has collaborated with esteemed professionals in the field of pharmaceuticals. Some of her coworkers include Aimee Richardson Usera and Zachary Hayes Robinson, with whom she has worked closely to bring groundbreaking innovations to fruition.

Conclusion: Jennifer Stroka Cobb's exceptional achievements and groundbreaking inventions highlight her as a trailblazer in the realm of medical innovation. Her work not only fosters advancements in treating complex medical conditions but also serves as an inspiration for aspiring inventors to push the boundaries of creativity and make a lasting impact on society.